J. Goldman & Co’s Abbott ABT Stock Holding History

J. Goldman & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-289,212	Closed	-$29.7M	–	692
2026 Q1	$29.7M	Buy	+289,212	New	+$32.7M	0.86%	13
2016 Q4	–	Sell	-115,782	Closed	-$4.9M	–	288
2016 Q3	$4.9M	Buy	+115,782	New	+$4.96M	0.28%	107

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

J. Goldman & Co's ABT Position: Q2 2026 in Review

J. Goldman & Co sold out of Abbott (ABT) in Q2 2026, closing a stake of 289,212 shares — an estimated $29.7M sold.

J. Goldman & Co first reported a position in ABT in Q3 2016 and held it in 2 quarters. The position peaked at $29.7M in Q1 2026. 2,969 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

J. Goldman & Co reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
J. Goldman & Co sold 289,212 Abbott shares in Q2 2026, an estimated $29.7M.
J. Goldman & Co first reported a position in Abbott in Q3 2016 and held it in 2 quarters.
J. Goldman & Co's Abbott position peaked at $29.7M in Q1 2026.
2,969 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.